Quantum Biopharma Ltd. Files 20-F/A Amendment
Ticker: QNTM · Form: 20-F/A · Filed: Mar 31, 2025 · CIK: 1771885
| Field | Detail |
|---|---|
| Company | Quantum Biopharma Ltd. (QNTM) |
| Form Type | 20-F/A |
| Filed Date | Mar 31, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, financials, pharmaceuticals
Related Tickers: QNTM
TL;DR
Quantum Biopharma (QNTM) filed its 20-F/A for FY24 on 3/31/25. Check financials.
AI Summary
Quantum Biopharma Ltd. filed a 20-F/A amendment on March 31, 2025, for the fiscal year ending December 31, 2024. The company, formerly known as FSD Pharma Inc., is based in Toronto and operates in the pharmaceutical preparations sector. The filing details financial information and business operations for the period.
Why It Matters
This filing provides updated financial and operational information for Quantum Biopharma Ltd., which is crucial for investors and stakeholders to assess the company's performance and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Quantum Biopharma faces inherent risks related to drug development, regulatory approvals, and market competition, which are typical for the industry.
Key Numbers
- 2834 — SIC Code (Standard Industrial Classification for Pharmaceutical Preparations)
- 001-39152 — SEC File Number (SEC file number for Quantum Biopharma Ltd.)
Key Players & Entities
- Quantum Biopharma Ltd. (company) — Filer of the 20-F/A amendment
- FSD Pharma Inc. (company) — Former name of Quantum Biopharma Ltd.
- 20250331 (date) — Filing date of the 20-F/A amendment
- 20241231 (date) — Fiscal year end for the report
- 0001771885 (company) — Central Index Key for Quantum Biopharma Ltd.
- Toronto (location) — City of business and mailing address
FAQ
What is the primary business of Quantum Biopharma Ltd.?
Quantum Biopharma Ltd. operates in the Pharmaceutical Preparations sector, as indicated by its SIC code 2834.
When was the company formerly known as?
The company was formerly known as FSD Pharma Inc., with a name change date of March 27, 2019.
What is the filing date of this 20-F/A amendment?
The 20-F/A amendment was filed on March 31, 2025.
What fiscal year does this report cover?
This report covers the fiscal year ending December 31, 2024.
Where is Quantum Biopharma Ltd. located?
Quantum Biopharma Ltd.'s business and mailing address is located in Toronto, Ontario, Canada.
Filing Details
This Form 20-F/A (Form 20-F/A) was filed with the SEC on March 31, 2025 regarding Quantum Biopharma Ltd. (QNTM).